Business ❯ Pharmaceuticals

Partnerships

Research and Development Distribution Agreements Marketing Product Development AI in Drug Development Investments Product Launches Investment Collaborations Technology Integration Licensing Agreements Emergent BioSolutions Radiopharmaceuticals Drug Development International Collaborations Collaboration Agreements Drug Marketing Research Funding Legend Biotech Drug Commercialization Oncology Product Distribution International Business Distribution

Regeneron and Telix Form 50/50 Partnership to Develop Targeted Radiopharmaceuticals

The tie-up points to growing big‑biotech interest in cancer drugs that deliver radiation directly to tumors and demand specialized manufacturing.

FDA Approves First Therapy for Acquired Hypothalamic Obesity, Expanding Rhythm’s Imcivree

Novo Nordisk Licenses Vivtex Platform in $2.1 Billion Push for Oral Obesity and Diabetes Drugs

Lilly and Innovent Forge Territory-Split Cancer and Immunology Alliance

Lilly, Repertoire Strike Up-to-$1.93 Billion Autoimmune Drug Pact

Bristol Myers to Use Microsoft’s Imaging Network to Deploy FDA-Cleared AI for Earlier Lung Cancer Detection

GSK Closes $12 Billion Licensing Pact for Hengrui’s COPD Therapy and 11 Preclinical Assets